Equifax EVP granted 22,958 restricted stock units

Smith David John reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Smith David John reported acquisition or exercise transactions in this Form 4 filing.

Equifax Inc. executive David John Smith, EVP and President of USIS, reported receiving two equity awards in the form of common stock on March 2, 2026 as part of the company’s long‑term incentive plan.

The first award covers 12,979 shares at a price of $0.00 per share, described in a footnote as a new hire grant of restricted stock units that vests in three equal annual increments beginning March 2, 2027. The second award covers 9,979 shares, noted as an annual equity grant of restricted stock units that vests 100% on March 2, 2029.

After these awards, Smith directly owns 22,958 shares of Equifax common stock, reflecting equity-based compensation rather than open‑market purchases or sales.

Insider Trade Summary

Grant/Award: 22,958 shares

Grant/Award 2 txns

Insider Smith David John

Role EVP, Pres USIS

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,979	$0.00	$0.00
Grant/Award	Common Stock	9,979	$0.00	$0.00

Holdings After Transaction: Common Stock — 22,958 shares (Direct)

Footnotes (2)

1. F1. New hire equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests in three equal annual increments beginning 3/2/2027.
2. F2. Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 3/2/2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity awards did Equifax (EFX) report for David John Smith?

Equifax reported that EVP David John Smith received two equity awards on March 2, 2026, totaling 22,958 shares of common stock. These are restricted stock unit grants under the company’s long‑term incentive plan, not open‑market purchases or sales.

How many shares were included in David John Smith’s new hire grant at Equifax (EFX)?

The new hire equity grant for David John Smith covers 12,979 shares tied to restricted stock units. According to the filing, this award vests in three equal annual installments beginning on March 2, 2027, aligning compensation with longer‑term service.

What is the vesting schedule for David John Smith’s annual equity grant at Equifax (EFX)?

The annual equity grant for David John Smith consists of 9,979 restricted stock units that vest 100% on March 2, 2029. This single‑cliff vesting structure encourages longer‑term retention and aligns his interests with future company performance over several years.

What is David John Smith’s Equifax (EFX) common stock ownership after these grants?

After the reported awards, David John Smith directly owns 22,958 shares of Equifax common stock. This total reflects the cumulative impact of the two restricted stock unit grants reported in the filing, both awarded at an indicated price of $0.00 per share.

Were David John Smith’s Equifax (EFX) equity transactions open-market trades?

No, the transactions are coded as “A” grants or awards, not open‑market trades. The filing states they are restricted stock unit grants under Equifax’s long‑term incentive plan, with no purchase price and defined vesting schedules rather than market purchases or sales.

Why did Equifax (EFX) grant restricted stock units to EVP David John Smith?

The filing states that one grant is a new hire equity grant and the other an annual equity grant under Equifax’s long‑term incentive plan. Such awards are used to provide equity-based compensation and align executive incentives with shareholder interests over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 09:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith David John

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Pres USIS

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/02/2026		A		12,979	A	$0.0000	12,979	D
Common Stock(2)	03/02/2026		A		9,979	A	$0.0000	22,958	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. New hire equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests in three equal annual increments beginning 3/2/2027.

2. Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 3/2/2029.

	/s/Lisa Stockard as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.